Next Article in Journal
Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model
Next Article in Special Issue
Norovirus Genetic Diversity in Children under Five Years Old with Acute Diarrhea in Mozambique (2014–2015)
Previous Article in Journal
Retraction: Jiang, H.; Mei, Y.-F. SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. Viruses 2021, 13, 2056
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Evaluation of Heat Inactivation of Human Norovirus in Freshwater Clams Using Human Intestinal Enteroids

1
Department of Virology II, National Institute of Infectious Diseases, Tokyo 208-0011, Japan
2
Production Engineering Division, Aquaculture Research Department, Fisheries Technology Institute, Japan Fisheries Research and Education Agency, Hiroshima 722-0061, Japan
3
Pathology Division, Aquaculture Research Department, Fisheries Technology Institute, Japan Fisheries Research and Education Agency, Minamiise 516-0913, Japan
4
Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA
5
Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
6
Department of Infectious Disease Research, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe 650-0047, Japan
*
Author to whom correspondence should be addressed.
Viruses 2022, 14(5), 1014; https://doi.org/10.3390/v14051014
Submission received: 22 March 2022 / Revised: 1 May 2022 / Accepted: 7 May 2022 / Published: 10 May 2022
(This article belongs to the Special Issue Norovirus and Foodborne Diseases)

Abstract

:
Foodborne disease attributed to the consumption of shellfish contaminated with human norovirus (HuNoV) is one of many global health concerns. Our study aimed to determine the conditions of the heat-inactivation of HuNoV in freshwater clams (Corbicula japonica) using a recently developed HuNoV cultivation system employing stem-cell derived human intestinal enteroids (HIEs). We first measured the internal temperature of the clam tissue in a water bath during boiling at 90 °C and found that approximately 2 min are required for the tissue to reach 90 °C. Next, GII.4 HuNoV was spiked into the center of the clam tissue, followed by boiling at 90 °C for 1, 2, 3, or 4 min. The infectivity of HuNoV in the clam tissue homogenates was evaluated using HIEs. We demonstrated that HuNoV in unboiled clam tissue homogenates replicated in HIEs, whereas infectivity was lost in all boiled samples, indicating that heat treatment at 90 °C for 1 min inactivates HuNoV in freshwater clams in our current HIE culture system. To our knowledge, this is the first study to determine the thermal tolerability of HuNoV in shellfish using HIEs, and our results could be informative for developing strategies to inactivate HuNoV in shellfish.

1. Introduction

Foodborne diseases attributed to the consumption of unsafe foods, which are contaminated with pathogens (bacteria, viruses, or parasites) or toxic chemical substances, cause 600 million people illness worldwide every year and therefore pose a major public health concern [1,2]. Foodborne disease is caused by several pathogens, including Campylobacter, Salmonella, Listeria, hepatitis A virus, and human norovirus (HuNoV). Among those, HuNoV is the most frequently detected pathogen in contaminated foods being consumed by ill individuals [1,3]. Shellfish, especially oysters, are recognized as one of the major sources for HuNoV-associated foodborne disease due to the accumulation of HuNoVs in the digestive gland by filter feeding [4].
The most common inactivation method of pathogens in contaminated foods is to cook them properly at a high temperature. Given the varied thermal tolerability of each pathogen, the establishment of tailor-made strategies to inactivate their respective pathogens is necessary to reduce the risk of foodborne illness. Concerning HuNoV, there was no robust HuNoV cultivation system developed until recently. Therefore, investigations on the food inactivation of HuNoV have been carried out by measuring copy numbers of the HuNoV genome or infectious virus titers of surrogate viruses, such as murine norovirus (MNV) and feline calicivirus (FCV) [5,6]. However, it remains unclear whether these indirect measures reflect the inactivation of HuNoV infectivity.
Recently, several HuNoV cultivation systems have been developed, including B cells [7], tissue stem cell-derived human intestinal enteroids (HIEs) [8,9], human induced pluripotent stem cell-derived intestinal epithelial cells (iPSC-derived IECs) [10] and zebrafish [11]. Studies using our HIE system, as well as human iPSC-derived IECs, show HuNoV inactivation by heating or disinfectants (alcohol or chlorine) [8,12,13]. However, to our knowledge, an investigation on HuNoV’s inactivation in foods such as bivalves using the HuNoV cultivation system has not been performed so far.
In this study, we evaluated the thermal inactivation conditions of freshwater clams artificially inoculated with HuNoV by measuring infectious HuNoV using the HIE culture system.

2. Materials and Methods

2.1. Measurement of Temperature Kinetics in Freshwater Clams Subjected to Heat Treatment

Live freshwater clams (Corbicula japonica) were purchased at a grocery store and maintained overnight at room temperature in diluted seawater. A whole clam body was then taken from its shell and transferred into a 1.5-mL tube. The weights of the clam bodies ranged from 0.16 g to 0.41 g (mean ± standard deviation (SD), 0.29 ± 0.07). To monitor the internal and external temperatures of the samples, two thermometers were used; a probe thermometer was inserted into a clam body (Figure 1A), and another was immersed in a water bath set at 90 °C (Figure 1B). Both temperatures were recorded every 15 s up to 5 min.

2.2. Preparation of HuNoV-Containing Stool Filtrate

Ten percent stool filtrate containing HuNoV was prepared as described previously with minor modifications [8]. Briefly, PBS was added to a HuNoV-positive stool and homogenized by vortexing and sonication. The suspensions were centrifuged at 12,000× g for 5 min at 4 °C, and the supernatant was passed serially through 5-µm and 0.22-µm filters. The samples were aliquoted and frozen at −80 °C before use.

2.3. Artificial Inoculation of HuNoV into Freshwater Clams Followed by Heat Treatment and Sample Processing

Six freshwater clams (one clam per each time point plus PBS control) were used in one experiment, and the experiment was repeated three times. Each clam body taken from its shell was injected with 30 μL of either PBS as a control or 10% stool filtrate containing 1.06 × 108 genome equivalents (GEs) of GII.4[GII.P16] HuNoV [14] using a 50-μL microsyringe with a fine needle. The relatively high titer of HuNoV was used for this purpose, because the resultant clam homogenate needed to be diluted to minimize its cytotoxicity in HIEs. The artificial inoculated samples were then left untreated or heat-treated at 90 °C for 1, 2, 3, or 4 min, as described above. After cooling the samples down to room temperature, 170 μL of chilled complete medium without growth factors (CMGF(-)) used for culturing HIEs was added to each sample. The clam bodies were then chopped with scissors and homogenized using a hand mixer (PowerMasher II, 891300, nippi, Tokyo, Japan) for 30 s, followed by centrifugation at 9100× g for 3 min at 4 °C. The supernatant was collected and repeated the centrifugation with the same condition to remove debris. The collected supernatant was stored at −80 °C until used for determining the virus infectivity and viral recovery efficiency. The final recovered volume was 160 ± 26 μL (PBS, 0 min), 193 ± 25 μL (HuNoV, 0 min), 210 ± 17 μL (HuNoV, 1 min), 177 ± 45 μL (HuNoV, 2 min), 220 ± 26 μL (HuNoV, 3 min), or 223 ± 23 μL (HuNoV, 4 min).

2.4. Evaluation of Infectivity of HuNoV in Clam Extracts Using HIEs

HIE culture and HuNoV infection were performed as described previously [8,14,15]. Briefly, a jejunal HIE (J2) culture, provided from the Baylor College of Medicine under the Material Transfer Agreement, was maintained and propagated as Matrigel-embedded, 3-dimensional (3D) HIEs in complete medium with growth factors (CMGF(+)) or IntestiCult Organoid Growth Medium (Human, STEMCELL, Vancouver, BC, Canada).
To prepare monolayer HIE cultures for HuNoV infection, the 3D HIEs (passages 25–28) were dissociated with TrypLE Express (Thermo Fisher, Waltham, MA USA) and seeded onto collagen IV-coated 96-well plates at the number of approximately ~105 cells/well in the CMGF(+) or IntestiCult media supplemented with ROCK inhibitor Y-27632 (10 μM, Sigma, Burlington, MA, USA) for 2 days. The medium was then replaced with IntestiCult Organoid Differentiation Medium (Human, STEMCELL), and the cultures were maintained for an additional 2 days. The monolayer HIEs were then inoculated with 5 μL of the clam samples diluted 1:20 in a final volume of 100 μL of CMGF(-) medium in the presence of 500 μM GCDCA, which promotes GII.4 HuNoV infection [8]. After 1 h of incubation at 37 °C, the cells were washed twice with CMGF(-) and further incubated in IntestiCult Organoid Differentiation Medium containing 500 μM GCDCA until 24 h post-infection (hpi). The cells and medium were then collected and subjected to RNA extraction using the Direct-zol RNA MiniPrep kit (Zymo Research, Irvine, CA, USA) following the manufacturer’s instructions. The RNA was eluted in 50 μL of distilled water.
HuNoV RNA genome equivalents (GEs) were determined by reverse transcription-quantitative PCR (RT-qPCR) analysis in a 20 μL reaction volume using a TaqMan Fast Virus 1-Step Master Mix (Thermo Fisher) and GII specific primer/probe sets [16]. Five microliters of RNA in each sample were used for this assay. A standard curve generated using plasmid-containing HuNoV genome sequences was used to quantitate viral GEs. We defined the limit of detection in the RT-qPCR analysis as 20 GEs/rxn (3.0 log10 GEs/well) based on a standard curve.

2.5. Evaluation of Viral Recovery Efficiency after Homogenization

The RNA was extracted from 5 μL of the inoculum containing 30 μL of HuNoV-containing stool filtrates mixed with 170 μL of CMGF(-) (input) or the HuNoV-inoculated clam extracts (samples) and then subjected to RT-qPCR analysis to measure the HuNoV GEs. The percentage of recovery efficiency was calculated as HuNoV GEs in clam samples relative to that in the inoculum.

2.6. Statistical Analysis

Statistical analysis was performed with ANOVA, followed by Dunnett’s multiple-comparison test or two-tailed Student’s t-test using GraphPad Prism 9 software. p-values of <0.05 were considered statistically significant.

3. Results

Heat treatment experiments were carried out using a water bath at 90 °C. Measurements of the internal and external temperatures during heating showed that, while the water temperature was stable at around 90 °C during the heating process, the temperature of the clam body required 2 min before reaching a stable temperature at 90 °C (Figure 1C).
We then evaluated the effects of different times of heat inactivation on the HuNoV-inoculated clams. The clam bodies were either spiked with PBS as a non-infection control or HuNoV using a microsyringe. The inoculated clam tissue, either left unheated or heated at 90 °C for 1, 2, 3, or 4 min, was homogenized. We first evaluated the recovery efficiency of spiked HuNoV in clam homogenates (Figure 2A and Figure S1). Approximately 60% of the inoculated HuNoV GEs (62.0 ± 7.3%) were recovered from HuNoV-spiked clam homogenates without heating, whereas the treatment at 90 °C for 1 min significantly reduced the recovery (27.7 ± 15.9%) as compared to the unheated samples. The treatment at 90 °C for 2 min further reduced the recovery (12.0 ± 3.5%), while the recovery remained unchanged thereafter (Figure 2A). In addition, to see if heated clam homogenates affect the recovery of HuNoV, we quantified HuNoV RNA extracted from pre- or post-heated clams inoculated with HuNoV. The results showed no significant difference of viral GEs between them (Figure S2).
Then, the infectious virus was quantified, following replication in the culture, by determining the viral GEs at 1 or 24 hpi, as described in the Materials and Methods section. HuNoV in clam homogenates was infectious and able to be replicated in HIEs showing a 42.5-fold increase in GEs at 24 hpi (4.5 ± 0.5 GEs/well) as compared to 1 hpi (3.0 ± 0.0 GEs/well), while the PBS-injected samples contained no infectious virus, as expected (Figure 2B). Furthermore, all groups of heat treatment showed no viral replication at 24 hpi, suggesting that the 90 °C for 1 min treatment inactivates HuNoV in clam bodies (Figure 2B), although improvement of the viral growth efficiency in HIEs is required for optimal inactivation studies, as discussed below.

4. Discussion

Generally, if no cultivation system is available to grow a certain human pathogen, employing cultivable surrogate virus(es) is used to study the biological characteristics, including tolerability against disinfectants or heating [6]. However, the properties of the surrogate viruses are not always the same as the human pathogen. Indeed, previous reports demonstrated that HuNoV is resistant to 70% alcohol [12], whereas surrogate viruses such as murine norovirus (MNV), feline calicivirus (FCV) and porcine enteric calicivirus, but not Tulane virus, are sensitive to this treatment [17]. A study on heat inactivation of MNV in shellfish showed that the heat treatment at 90 °C for 90 s resulted in an approximate 2 log10 reduction of the infectious virus measured by using plaque assays [5]. The authors also demonstrated that the 90 °C for 180 s completely inactivated MNV and hepatitis A virus (HAV), another important human pathogen related to viral foodborne illness [5]. Whether the heat treatment at 90 °C for 1 min is sufficient for the inactivation of MNV or HAV, as well as HuNoV, remains to be verified.
Recently, a propidium monoazide (PMA) viability RT-qPCR assay, which is expected to measure only infectious virions containing intact viral RNA but not non-infectious virions containing degraded RNA, was applied to study the inactivation of HuNoV in clams [18]. That study demonstrated that HuNoV spiked in clams and heated at 90 °C for 10 min resulted in a 3.52 log10 reduction of HuNoVs determined by a PMA viability RT-qPCR assay [18]. Since the growth of HuNoVs in HIEs is still lower than that of surrogate viruses in their cultivable cells, improvement of the growth efficiency is required to be utilized as general evaluation methods for HuNoV inactivation. For example, conditions to cultivate HuNoV in genetically modified lines and with improved medium conditions to achieve at least three logs of replication are being sought for optimal inactivation studies [9,19]. In addition, the improvement of the HuNoV quantification method (e.g., lowering of the limit of detection in RT-qPCR analysis) is required for applying to actual contaminated samples that might be destined for heat inactivation. Meanwhile, comparisons between the PMA viability RT-qPCR assay and our evaluation method using HIEs would be beneficial to develop a general pragmatic method to evaluate HuNoV inactivation.
In this study, we used freshwater clams to evaluate HuNoV inactivation using HIEs, because the HuNoV genome is frequently detected in clams, as well as oysters, among bivalve mollusks [20]. It would be worth comparing HuNoV inactivation patterns in between clams and oysters, which needs further investigation.
In summary, we evaluated the heat inactivation of HuNoV in freshwater clams using HIEs and showed that treatment at 90 °C for 1 min inactivates HuNoV in the clam bodies. Although our current HIE system is suboptimal for evaluating actual contaminated samples, this information could be valuable when developing guidelines to inactivate HuNoV, which will contribute to reducing the risk of foodborne illness associated with HuNoV.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/v14051014/s1: Figure S1: Raw data for Figure 2A. Recovery of HuNoV in freshwater clams after heat treatment. Figure S2: Recovery of HuNoV in the presence of heated clam tissue.

Author Contributions

K.M. conceived and supervised the project. K.M. and T.H. designed the experiments and wrote the manuscript. T.H., Y.Y. and K.M. conducted the experiments and analyzed the results. A.I., T.K., R.S., M.M. and M.K.E. provided advice for the study, discussed the results, and critically reviewed the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Ministry of Health Labour and Welfare of Japan, Grant JPMH19KA1006 and JPMH22KA1001 (to K.M.); the Japan Agency for Medical Research and Development (AMED), Grants JP21fk0108121 and JP21fk0108149 (to K.M.) and JP21fk0108102 and JP21wm0225009 (to M.M.), and NIH Grants P30 DK056338 and PO1 AI057788 (to M.K.E.).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data are presented in the article, and further inquiries can be directed to the corresponding author.

Acknowledgments

We thank the research group of freshwater clams in Japan for kind support for clam handling.

Conflicts of Interest

M.K.E. is named as an inventor on patents related to cloning and cultivation of the Norwalk virus genome and has been a consultant to and received research funding from Takeda Vaccines, Inc.

References

  1. Lee, H.; Yoon, Y. Etiological Agents Implicated in Foodborne Illness World Wide. Food Sci. Anim. Resour. 2021, 41, 1–7. [Google Scholar] [CrossRef] [PubMed]
  2. WHO. Food Safety. 2020. Available online: https://www.who.int/NEWS-ROOM/FACT-SHEETS/DETAIL/FOOD-SAFETY (accessed on 11 November 2021).
  3. WHO. WHO Estimates of the Global Burden of Foodborne Diseases. 2015. Available online: https://apps.who.int/iris/bitstream/handle/10665/199350/9789241565165_eng.pdf?sequence=1 (accessed on 11 November 2021).
  4. Ludwig-Begall, L.F.; Mauroy, A.; Thiry, E. Noroviruses-The State of the Art, Nearly Fifty Years after Their Initial Discovery. Viruses 2021, 13, 1541. [Google Scholar] [CrossRef] [PubMed]
  5. Sow, H.; Desbiens, M.; Morales-Rayas, R.; Ngazoa, S.E.; Jean, J. Heat inactivation of hepatitis A virus and a norovirus surrogate in soft-shell clams (Mya arenaria). Foodborne Pathog. Dis. 2011, 8, 387–393. [Google Scholar] [CrossRef] [PubMed]
  6. Bozkurt, H.; D’Souza, D.H.; Davidson, P.M. Thermal Inactivation of Foodborne Enteric Viruses and Their Viral Surrogates in Foods. J. Food Prot. 2015, 78, 1597–1617. [Google Scholar] [CrossRef] [PubMed]
  7. Jones, M.K.; Watanabe, M.; Zhu, S.; Graves, C.L.; Keyes, L.R.; Grau, K.R.; Gonzalez-Hernandez, M.B.; Iovine, N.M.; Wobus, C.E.; Vinjé, J.; et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science 2014, 346, 755–759. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Ettayebi, K.; Crawford, S.E.; Murakami, K.; Broughman, J.R.; Karandikar, U.; Tenge, V.R.; Neill, F.H.; Blutt, S.E.; Zeng, X.L.; Qu, L.; et al. Replication of human noroviruses in stem cell-derived human enteroids. Science 2016, 353, 1387–1393. [Google Scholar] [CrossRef] [PubMed]
  9. Ettayebi, K.; Tenge, V.R.; Cortes-Penfield, N.W.; Crawford, S.E.; Neill, F.H.; Zeng, X.L.; Yu, X.; Ayyar, B.V.; Burrin, D.; Ramani, S.; et al. New Insights and Enhanced Human Norovirus Cultivation in Human Intestinal Enteroids. mSphere 2021, 6, e01136-20. [Google Scholar] [CrossRef] [PubMed]
  10. Sato, S.; Hisaie, K.; Kurokawa, S.; Suzuki, A.; Sakon, N.; Uchida, Y.; Yuki, Y.; Kiyono, H. Human Norovirus Propagation in Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells. Cell Mol. Gastroenterol. Hepatol. 2019, 7, 686.e685–688.e685. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Van Dycke, J.; Ny, A.; Conceição-Neto, N.; Maes, J.; Hosmillo, M.; Cuvry, A.; Goodfellow, I.; Nogueira, T.C.; Verbeken, E.; Matthijnssens, J.; et al. A robust human norovirus replication model in zebrafish larvae. PLoS Pathog. 2019, 15, e1008009. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Costantini, V.; Morantz, E.K.; Browne, H.; Ettayebi, K.; Zeng, X.L.; Atmar, R.L.; Estes, M.K.; Vinjé, J. Human Norovirus Replication in Human Intestinal Enteroids as Model to Evaluate Virus Inactivation. Emerg. Infect. Dis. 2018, 24, 1453–1464. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Sato, S.; Matsumoto, N.; Hisaie, K.; Uematsu, S. Alcohol abrogates human norovirus infectivity in a pH-dependent manner. Sci. Rep. 2020, 10, 15878. [Google Scholar] [CrossRef] [PubMed]
  14. Hayashi, T.; Murakami, K.; Hirano, J.; Fujii, Y.; Yamaoka, Y.; Ohashi, H.; Watashi, K.; Estes, M.K.; Muramatsu, M. Dasabuvir Inhibits Human Norovirus Infection in Human Intestinal Enteroids. mSphere 2021, 6, e0062321. [Google Scholar] [CrossRef] [PubMed]
  15. Murakami, K.; Tenge, V.R.; Karandikar, U.C.; Lin, S.C.; Ramani, S.; Ettayebi, K.; Crawford, S.E.; Zeng, X.L.; Neill, F.H.; Ayyar, B.V.; et al. Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids. Proc. Natl. Acad. Sci. USA 2020, 117, 1700–1710. [Google Scholar] [CrossRef] [PubMed]
  16. Kageyama, T.; Kojima, S.; Shinohara, M.; Uchida, K.; Fukushi, S.; Hoshino, F.B.; Takeda, N.; Katayama, K. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J. Clin. Microbiol. 2003, 41, 1548–1557. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Cromeans, T.; Park, G.W.; Costantini, V.; Lee, D.; Wang, Q.; Farkas, T.; Lee, A.; Vinjé, J. Comprehensive comparison of cultivable norovirus surrogates in response to different inactivation and disinfection treatments. Appl. Environ. Microbiol. 2014, 80, 5743–5751. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Fuentes, C.; Pérez-Rodríguez, F.J.; Sabrià, A.; Beguiristain, N.; Pintó, R.M.; Guix, S.; Bosch, A. Inactivation of Hepatitis A Virus and Human Norovirus in Clams Subjected to Heat Treatment. Front. Microbiol. 2021, 11, 578328. [Google Scholar] [CrossRef] [PubMed]
  19. Lin, S.C.; Qu, L.; Ettayebi, K.; Crawford, S.E.; Blutt, S.E.; Robertson, M.J.; Zeng, X.L.; Tenge, V.R.; Ayyar, B.V.; Karandikar, U.C.; et al. Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc. Natl. Acad. Sci. USA 2020, 117, 23782–23793. [Google Scholar] [CrossRef] [PubMed]
  20. Guix, S.; Pintó, R.M.; Bosch, A. Final Consumer Options to Control and Prevent Foodborne Norovirus Infections. Viruses 2019, 11, 333. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Kinetics of the internal temperature in clams subjected to heat treatment. A thermometer probe was inserted into a clam body in a 1.5-mL tube to measure the internal temperature of the clam (A). A second thermometer probe was put in the water bath to measure the temperature outside the 1.5-mL tube (B). The internal clam tissue temperature and the external water bath temperature were recorded every 15 s up to 5 min (C). The results are shown as the mean ± standard deviation calculated from 5 independent experiments (n = 5).
Figure 1. Kinetics of the internal temperature in clams subjected to heat treatment. A thermometer probe was inserted into a clam body in a 1.5-mL tube to measure the internal temperature of the clam (A). A second thermometer probe was put in the water bath to measure the temperature outside the 1.5-mL tube (B). The internal clam tissue temperature and the external water bath temperature were recorded every 15 s up to 5 min (C). The results are shown as the mean ± standard deviation calculated from 5 independent experiments (n = 5).
Viruses 14 01014 g001
Figure 2. Thermal inactivation of HuNoV in freshwater clams. The clam tissue was spiked with either PBS or HuNoV-containing stool filtrate. The spiked clam tissue was next left untreated or heat-treated at 90 °C for 1, 2, 3, or 4 min and then homogenized. (A) Viral GEs in the clam extracts were quantified by RT-qPCR, and the recovery efficiency was calculated as in the Materials and Methods. ** p < 0.01 vs. unheated HuNoV-spiked clam samples (0 min), one-way ANOVA followed by Dunnett’s multiple comparison test. (B) The samples were inoculated against differentiated HIEs, and HuNoV GEs in the HIEs were determined as in the Materials and Methods. The limit of detection in the RT-qPCR analysis is 3.0 log10 GEs/well. ** p < 0.01, two-tailed Student’s t-test. Results are shown as the mean ± standard the deviation calculated from 3 independent experiments (n = 3).
Figure 2. Thermal inactivation of HuNoV in freshwater clams. The clam tissue was spiked with either PBS or HuNoV-containing stool filtrate. The spiked clam tissue was next left untreated or heat-treated at 90 °C for 1, 2, 3, or 4 min and then homogenized. (A) Viral GEs in the clam extracts were quantified by RT-qPCR, and the recovery efficiency was calculated as in the Materials and Methods. ** p < 0.01 vs. unheated HuNoV-spiked clam samples (0 min), one-way ANOVA followed by Dunnett’s multiple comparison test. (B) The samples were inoculated against differentiated HIEs, and HuNoV GEs in the HIEs were determined as in the Materials and Methods. The limit of detection in the RT-qPCR analysis is 3.0 log10 GEs/well. ** p < 0.01, two-tailed Student’s t-test. Results are shown as the mean ± standard the deviation calculated from 3 independent experiments (n = 3).
Viruses 14 01014 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Hayashi, T.; Yamaoka, Y.; Ito, A.; Kamaishi, T.; Sugiyama, R.; Estes, M.K.; Muramatsu, M.; Murakami, K. Evaluation of Heat Inactivation of Human Norovirus in Freshwater Clams Using Human Intestinal Enteroids. Viruses 2022, 14, 1014. https://doi.org/10.3390/v14051014

AMA Style

Hayashi T, Yamaoka Y, Ito A, Kamaishi T, Sugiyama R, Estes MK, Muramatsu M, Murakami K. Evaluation of Heat Inactivation of Human Norovirus in Freshwater Clams Using Human Intestinal Enteroids. Viruses. 2022; 14(5):1014. https://doi.org/10.3390/v14051014

Chicago/Turabian Style

Hayashi, Tsuyoshi, Yoko Yamaoka, Atsushi Ito, Takashi Kamaishi, Ryuichi Sugiyama, Mary K. Estes, Masamichi Muramatsu, and Kosuke Murakami. 2022. "Evaluation of Heat Inactivation of Human Norovirus in Freshwater Clams Using Human Intestinal Enteroids" Viruses 14, no. 5: 1014. https://doi.org/10.3390/v14051014

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop